Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8453)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 25, 2022 (publication date) through Jul 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Virology
ISSN
2220-3249
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leowattana W, Leowattana T. Chronic hepatitis B: New potential therapeutic drugs target. World J Virol 2022; 11(1): 57-72 [PMID: 35117971 DOI: 10.5501/wjv.v11.i1.57] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v11/i1/57.htm |
| Number | Citing Articles |
| 1 |
Yasunari Matsuzaka, Ryu Yashiro. In Silico Protein Structure Analysis for SARS-CoV-2 Vaccines Using Deep Learning. BioMedInformatics 2023; 3(1): 54 doi: 10.3390/biomedinformatics3010004
|
| 2 |
Dimitrios Moianos, Maria Makri, Georgia-Myrto Prifti, Aristeidis Chiotellis, Alexandros Pappas, Molly E. Woodson, Razia Tajwar, John E. Tavis, Grigoris Zoidis. N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H. Molecules 2024; 29(12): 2942 doi: 10.3390/molecules29122942
|
| 3 |
Minh-Cong Hoang, Hong-Quan Duong, Van-Duyet Le, Thi-Thuy-Nga Nguyen, Van-Lang Ngo, The-Hung Dang. Hepatitis B virus genotypes and antiviral drug resistance mutations in treatment-naïve patients with chronic hepatitis B in Bacninh, Vietnam: a cross-sectional study. Therapeutic Advances in Infectious Disease 2025; 12 doi: 10.1177/20499361251344784
|
| 4 |
Alla Turshudzhyan, Micheal Tadros. Cautious optimism in anticipation of hepatitis B curative therapies. World Journal of Virology 2022; 11(4): 212-215 doi: 10.5501/wjv.v11.i4.212
Abstract(728) |
Core Tip(704) |
Full Article(HTML)(1758)
|
Full Article (PDF)-626K(210)
|
Full Article (Word)-105K(47)
|
Audio-1135K(2)
|
Peer-Review Report-319K(108)
|
Answering Reviewers-326K(101)
|
Times Cited (0)
|
Total Visits (6652)
|
Open
|
| 5 |
Yang Shi, Zihan Wang, Jingjing Xu, Wenxia Niu, Yubin Wu, Huiyu Guo, Jinmiao Shi, Zonglin Li, Baorong Fu, Yunda Hong, Zikang Wang, Wenjie Guo, Dabing Chen, Xingling Li, Qian Li, Shaojuan Wang, Jiahua Gao, Aling Sun, Yaosheng Xiao, Jiali Cao, Lijuan Fu, Yangtao Wu, Tianying Zhang, Ningshao Xia, Quan Yuan. TCR-like bispecific antibodies toward eliminating infected hepatocytes in HBV mouse models. Emerging Microbes & Infections 2024; 13(1) doi: 10.1080/22221751.2024.2387448
|
| 6 |
Rupchand Sutradhar, D.C. Dalal. Exploration of Hepatitis B Virus Infection Dynamics through an Intracellular Model. Journal of Theoretical Biology 2025; 611: 112189 doi: 10.1016/j.jtbi.2025.112189
|
| 7 |
Xiaohan Hu, Liwei Zhao, Mingrong Ou, Yuxin Chen, Hongxia Wei, Yanyan Xia, Hongpan Xu, Miao Li, Jun Wang. Evaluation of reverse transcription-polymerase chain reaction and simultaneous amplification and testing for quantitative detection of serum hepatitis B virus RNA. Heliyon 2023; 9(8): e18557 doi: 10.1016/j.heliyon.2023.e18557
|
| 8 |
Youlu Pan, Heye Xia, Yanwen He, Shenxin Zeng, Zhengrong Shen, Wenhai Huang. The progress of molecules and strategies for the treatment of HBV infection. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1128807
|
| 9 |
Ernest C. Agwamba, Hitler Louis, Innocent Benjamin, Chioma G. Apebende, Tomsmith O. Unimuke, Henry O. Edet, Akaninyene Udoikono, Adanna D. Nwagu, Adedapo S. Adeyinka. (E)-2-((3-Nitrophenyl)Diazenyl)-3-Oxo-3-Phenylpropanal: Experimental, DFT Studies, and Molecular Docking Investigations. Chemistry Africa 2022; 5(6): 2131 doi: 10.1007/s42250-022-00468-4
|
| 10 |
L VANEKOVA, M POLIDAROVA, V CHARVAT, Z VAVRINA, V VEVERKA, G BIRKUS, A BRAZDOVA. Development and Characterization of a Chronic Hepatitis B Murine Model With a Mutation in the START Codon of an HBV Polymerase. Physiological Research 2023; 72(1): 37 doi: 10.33549/physiolres.934979
|
| 11 |
Thu Kim Nguyen, Duyet Van Le. Resistant mutations within the hepatitis B virus reverse transcriptase sequence in treatment failure patients with chronic HBV infection in Vietnam. Journal of Global Antimicrobial Resistance 2023; 33: 35 doi: 10.1016/j.jgar.2023.02.013
|
| 12 |
Sajad Ahmad Bhat, Syed Kazim Hasan, Zahoor Ahmad Parray, Zaheenul Islam Siddiqui, Shabnam Ansari, Ayesha Anwer, Saniya Khan, Fatima Amir, Mahboubeh Mehmankhah, Asimul Islam, Zarrin Minuchehr, Syed Naqui Kazim. Potential antiviral activities of chrysin against hepatitis B virus. Gut Pathogens 2023; 15(1) doi: 10.1186/s13099-023-00531-6
|
| 13 |
Naveen Kumar, Narendra S. Choudhary. Managing HBV and HCV Infection Pre- and Post-liver Transplant. Journal of Clinical and Experimental Hepatology 2024; 14(2): 101287 doi: 10.1016/j.jceh.2023.09.008
|
| 14 |
Qing-Li Yang, Xi-Wei Lu, Zhong-Liao Fang, Yu-Qiu Gao, Yi-Ning He, Yan Huang, Yue Dai, Ming-Yong Liang, Carlos H. F. Chan, Zhi-Hua Jiang. The association between Clonorchis sinensis seropositivity and hepatocellular carcinoma in an endemic area: a study in Guangxi, China. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-10675-2
|
| 15 |
Rupchand Sutradhar, D. C. Dalal. Proceedings of the 2nd International Conference on Nonlinear Dynamics and Applications (ICNDA 2024), Volume 2. Springer Proceedings in Physics 2024; 315: 33 doi: 10.1007/978-3-031-69134-8_3
|
| 16 |
Xiaojiao Li, Jia Xu, Jixuan Sun, Jingrui Liu, Min Wu, Hong Zhang, Xiaoxue Zhu, Cuiyun Li, Yingjun Zhang, Jing Zhu, Yujie Chen, Lin Luo, Qingwei He, Yulei Zhuang, Yunfu Chen, Junqi Niu, Yanhua Ding. Safety, Pharmacokinetics and Antiviral Efficacy of Capsid Assembly Modulator Freethiadine in Healthy Volunteers and Chronic Hepatitis B Patients. Liver International 2025; 45(1) doi: 10.1111/liv.16213
|
| 17 |
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Osamu Yoshida, Julio Aguilar, Guillen Nieto Gerardo, Yoichi Hiasa. Development of Therapy Based on the Exploration of Biological Events Underlying the Pathogenetic Mechanisms of Chronic Hepatitis B Infection. Biomedicines 2023; 11(7): 1944 doi: 10.3390/biomedicines11071944
|
| 18 |
Maria Pfefferkorn, Jessica Brehm, Martin Brehm, Fanny Honshoven, Danilo Deichsel, Laura Vernoux, Vedran Pavlovic, Cynthia Wat, Thomas Berg, Florian van Bömmel. Overrange dilution for improvement of hepatitis B core related antigen as a biomarker: protocol validation and examples for application. Virology 2025; 609: 110576 doi: 10.1016/j.virol.2025.110576
|
| 19 |
Chengqian Feng, Jingrong Shi, Yunfu Chen, Sisi Chen, Jianping Cui, Jun Zhang, Xiaowen Zheng, Yaping Wang, Feng Li. A hepatitis B virus-free cccDNA-producing stable cell for antiviral screening. Antiviral Research 2025; 237: 106143 doi: 10.1016/j.antiviral.2025.106143
|
| 20 |
Edward J. Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, William Sievert, Wattana Sukeepaisarnjaroen, Alexander J. Thompson, Vedran Pavlovic, Bernadette Surujbally, Cynthia Wat, Bob D. Brown, Hardean E. Achneck, Man-Fung Yuen. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection. Journal of Hepatology 2023; 79(5): 1139 doi: 10.1016/j.jhep.2023.07.026
|